drugset / Trial / NCT05457491

Novel Antiaging Regenerative Skin Care Regimen Containing Human Platelet Extract (HPE)

NCT05457491 ↗

Phase 1 Terminated 56 enrolled Mayo Clinic
NaSingle-groupOpen-labelOther

Summary

The Researchers are trying to study a cosmetic skin care product called human platelet extract (HPE) to see if it can be used as a possible treatment for skin anti-aging and skin rejuvenation. They are trying find out the safety and tolerability of topical HPE after multiple doses of topical administration

Timeline

Start
2021-10-01
Primary completion
2022-07-07
Completion
2022-07-07

Outcome

Outcome not reported

Stopped: “Principal Investigator discretion”

Drugs

EvaluationDrugModalityDoseRoute
Subject Human platelet extract Unknown — Topical

Indications